BeOne Medicines (ONC) Cash from Investing Activities (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.72% |
| Dec 31, 2025 | 22.20% |
| Sep 30, 2025 | 26.02% |
| Jun 30, 2025 | 45.38% |
| Mar 31, 2025 | -30.27% |
| Dec 31, 2024 | 30.08% |
| Sep 30, 2024 | -20.58% |
| Jun 30, 2024 | 47.09% |
| Mar 31, 2024 | -235.28% |
| Dec 31, 2023 | 66.40% |
| Sep 30, 2023 | -374.74% |
| Jun 30, 2023 | -71.87% |
| Mar 31, 2023 | 525.55% |
| Dec 31, 2022 | -77.26% |
| Sep 30, 2022 | -74.27% |
| Jun 30, 2022 | 213.09% |
| Mar 31, 2022 | 1,091.91% |
| Dec 31, 2021 | -76.83% |
| Sep 30, 2021 | -104.77% |
| Jun 30, 2021 | -13.82% |
| Mar 31, 2021 | 435.86% |
| Dec 31, 2020 | 94.34% |
| Sep 30, 2020 | -257.43% |
| Jun 30, 2020 | 61.44% |
| Mar 31, 2020 | -4,566.70% |
| Dec 31, 2019 | -111.18% |
| Sep 30, 2019 | 11.26% |
| Jun 30, 2019 | 11.36% |
| Mar 31, 2019 | -19.15% |
| Dec 31, 2018 | 143.46% |
| Sep 30, 2018 | -1,537.47% |
| Jun 30, 2018 | 108.66% |
| Mar 31, 2018 | -477.87% |
| Dec 31, 2017 | 83.00% |
| Sep 30, 2017 | -675.74% |
| Jun 30, 2017 | 60.09% |
| Mar 31, 2017 | 125.51% |
| Dec 31, 2016 | -487.33% |
| Sep 30, 2016 | 132.52% |
| Jun 30, 2016 | -435.99% |
| Mar 31, 2016 | 452.49% |
| Dec 31, 2015 | 16.76% |
| Sep 30, 2015 | 108.26% |
| Jun 30, 2015 | -2,442.71% |